AngioDynamics and Immunophotonics Announces Partnership to Explore the Power of Immunotherapy
February 27, 2024 | Company
AngioDynamics, Inc. (NASDAQ: ANGO) and Immunophotonics, Inc. are pleased to announce a partnership that will com...
Read more >
Positive one-year follow-up data from Phase 2 trial of denovoSkin™
February 14, 2024 | Company
CUTISS AG has announced positive one-year follow-up data from its Phase 2 clinical trial of the lead product den...
Read more >
Faster insights for developing new medicines
November 30, 2023 | Company
CASE STUDY: Drug discovery and development company Eikon Therapeutics is using Pliops XDP in Starfish Storage t...
Read more >
Climeworks, Deep Sky unveil catalytic partnership in Canada to expand carbon removal in North America
| Company
Climeworks and Deep Sky, a Montreal-based CDR project developer, agreed to explore the development of large-scal...
Read more >
Immunophotonics announces 1st patient dosed in the United States
October 10, 2023 | Company
Immunophotonics, Inc., along with Dr. Robert CG Martin II, M.D, PhD, PACS, who serves as the Principal Investiga...
Read more >
Immunophotonics Announces 1st Patient Dosed in Multinational Clinical trial in France
September 21, 2023 | Company
Immunophotonics has announced the recruitment and the dosing of its first patient in France at Hôpital Foch in ...
Read more >